1OA Stock Overview
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Blueberries Medical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.02 |
| 52 Week Low | CA$0.001 |
| Beta | 1.99 |
| 11 Month Change | -16.67% |
| 3 Month Change | -37.50% |
| 1 Year Change | -28.57% |
| 33 Year Change | -91.15% |
| 5 Year Change | -92.86% |
| Change since IPO | -97.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1OA | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -44.4% | -5.0% | -1.3% |
| 1Y | -28.6% | -22.0% | 7.4% |
Return vs Industry: 1OA underperformed the German Pharmaceuticals industry which returned -21.6% over the past year.
Return vs Market: 1OA underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| 1OA volatility | |
|---|---|
| 1OA Average Weekly Movement | 33.2% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1OA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 1OA's weekly volatility has decreased from 59% to 33% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Facundo Garreton | blueberriesmed.com |
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. The company is based in Vancouver, Canada.
Blueberries Medical Corp. Fundamentals Summary
| 1OA fundamental statistics | |
|---|---|
| Market cap | €4.09m |
| Earnings (TTM) | -€879.64k |
| Revenue (TTM) | €196.90k |
20.8x
P/S Ratio-4.6x
P/E RatioIs 1OA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1OA income statement (TTM) | |
|---|---|
| Revenue | CA$288.29k |
| Cost of Revenue | CA$186.37k |
| Gross Profit | CA$101.92k |
| Other Expenses | CA$1.39m |
| Earnings | -CA$1.29m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0032 |
| Gross Margin | 35.35% |
| Net Profit Margin | -446.76% |
| Debt/Equity Ratio | 0% |
How did 1OA perform over the long term?
See historical performance and comparison